Settings Today

2022 preview: Expect a row over controversial Alzheimer's drug

In 2021, the US approved the first drug designed to treat the cause of Alzheimer's, but the European Union rejected it. Whether the drug can actually treat the chief symptoms of the disease will be a point of contention in 2022

Published 1217 days ago

Go Back to Reading NewsBack Read News Collect this News Article

Login to Continue, We will bring you back to this content 0



For peering opportunity Autonomouse System Number: AS401345 Custom Software Development at ErnesTech Email Address[email protected]